WFSA Fresenius Kabi Anaesthesia Innovation Awards
Applications now open for the WFSA Fresenius Kabi Anaesthesia Innovation Awards 2019
The WFSA and Fresenius Kabi are delighted to announce that we have launched the third round of this unique innovation development awards programme which identifies and supports the development of innovations that have the potential to transform the field of anaesthesia and improve patient safety worldwide. One award has been given each year for the duration of this three-year project, and 2019 is the third and final round.
Encouraging applications from around the world, the WFSA Fresenius Kabi Anaesthesia Innovation Awards will identify innovations in the field of anaesthesia which have the potential to benefit patients worldwide. Innovations can relate to anaesthesia, critical care or pain and be:
• A new product/ device
• An IT innovation
• A new techniques or solution of a problem
• An innovation in education or training in anaesthesiology
Successful awardees will be offered:
• A grant of up to $25,000 which must be spent on activities which will develop and help take the product or technology to a stage at which it is sufficiently developed to be brought to market or be attractive to follow-on funders or investors. Activities could include but are not limited to research consultancy, development of a prototype, small scale production, user testing, and marketing/business advice and will be determined in partnership with the WFSA Innovation Mentor.
• Input and feedback on their project from a panel of WFSA and Fresenius Kabi specialists
• A WFSA Innovation Mentor and Fresenius Kabi Business Mentor
• The opportunity to have a short promotional film made about their innovation
• An invitation to attend the WCA 2020 and contribute to the scientific programme
Eligibility of Applicants:
• Applications will only be accepted from individual anaesthesiologists who are nationals or residents of countries that have a national or regional society membership of the WFSA. A full list of WFSA Member Societies can be found here. An anaesthesiologist is a qualified specialist physician who has completed a nationally recognised medical training programme in anaesthesiology.
• If the application is made on behalf of a group, please choose one member of the group who would lead or represent the group.
• In submitting your application, you confirm that you are eligible to do so. The WFSA may require you to provide proof that you are eligible to apply.
• There is a limit of one application per person.
• The WFSA reserves all rights to disqualify you if you do not have the rights to the submission that you have made and the subject of such submission.
• All applicants must have read and agreed to the Terms & Conditions of the award.
How to Apply:
Please complete your online application here. You will need to provide details of your innovation as well as the progress you have made so far and any further supporting information in regards to your innovation you would like to add.
Applicants will be assessed by a panel of judges led by the WFSA Scientific Affairs Committee, and successful applicants will be notified before the 15th of October.The deadline for applications is the 31st August 2019.
WFSA Announces Winner of 2018 WFSA-Fresenius-Kabi Anaesthesia Innovation Awards
The World Federation of Societies of Anaesthesiologists (WFSA) is proud to announce the winner of the 2018 WFSA-Fresenius Kabi Anaesthesia Innovation Awards as RevoCap: A Revolution in Global Capnography, an innovation presented by Maziar Mohsen Nourian and Dr Michael Lipnick.
Maziar Mohsen Nourian, a medical student at the University of Utah, School of Medicine and Dr Michael Lipnick, an assistant professor at University of California, San Francisco (UCSF), Anaesthesia Division of Global Health Equity have been awarded the 2018 Innovation Award for the creation of an affordable and context-appropriate capnography device for use in low and middle income countries.
Started and led by Maziar Nourian, a medical student, and Patrick Kolbay, an engineering PhD student at the University of Utah with the counsel and support of faculty members within the department of Anaesthesiology, RevoCap is an innovation to help provide safer anaesthesia in Low and Middle Income countries. The University of Utah and UCSF are collaborating to help understand the gap in access to capnography worldwide and the potential impact of increasing access to capnography through the development of lower cost and context appropriate devices.
Michael and Maziar write:
“There have been multiple calls to action for universal access to capnography in order to improve patient safety in resource-constrained countries, yet reliable and affordable capnography monitors for these settings are still not available. We have created a prototype of a low-cost capnography device (RevoCap)...using commonly available components. The simple design is affordable and context-appropriate for LMICs.”
As award winners, Michael and Maziar will receive a grant of $25,000 to develop, test and refine the RevoCap prototype and will be able to access input, mentorship and feedback from WFSA and Fresenius Kabi specialists. Additionally, they will be offered the opportunity to have a short promotional film made about the innovation and will receive an invitation to attend the World Congress of Anaesthesia (WCA) in Prague 2020 to contribute to the scientific programme.
The WFSA would like to take this opportunity to send a huge congratulations to Maziar Mohsen Nourian and Dr Michael Lipnick. We look forward to working with them both in their development of RevoCap which has the potential to transform the field of anaesthesia and improve patient safety worldwide.